Three FDA offices open doors in China
This article was originally published in The Silver Sheet
Executive Summary
FDA opened three new offices in China the week of Nov. 17 in a move approved by the U.S. State Department in March. The eight FDA senior staffers selected to work in the Beijing, Guangzhou and Shanghai offices are inspectors and senior technical experts in foods, medicines and medical devices, the U.S. Department of Health and Human Services notes. "By having a presence in other parts of the world, we can work more closely with manufacturers and other governments, better share best practices and further ensure ... quality and safety," says HHS Secretary Mike Leavitt, who, along with FDA Commissioner Andrew von Eschenbach, traveled to the three cities late last month to meet with manufacturers and Chinese government officials to discuss policy and governance reforms aimed at improving the safety of medical products and food. HHS also is working to have an FDA presence in India, Europe, Latin America and the Middle East